Clinical Trial Update: Phase I EGFR BATs in Newly Diagnosed Glioblastoma [Phase 1]

View source ↗

Summary

A Phase I trial evaluating EGFR BATs in newly diagnosed glioblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• EGFR BATs

Snippet

Sponsor: University of Virginia | Conditions: Glioblastoma, Glioblastoma Multiforme | Phase 1 | Status: COMPLETED